High school girl students.
Conditions
Interventions
Intervention 1: Intervention group: Mediterranean-DASH Diet Intervention for Neurodegenerative Delay The MIND diet is a com
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 17 Years
Inclusion criteria
Inclusion criteria: High school girls aged 15 to 17 years Informed consent of participants and their parents Having regular menstruation
Exclusion criteria
Exclusion criteria: cardiovascular diseases History of liver and kidney disease Suffering from cancer or a history of cancer Having a known cardiovascular disease or a history of heart surgery Having type 2 diabetes (fasting blood sugar above 126) or type 1 diabetes Recipient of a special diet Having any underlying disease People who do professional sports or are athletes Allergy to any of the components of the MIND diet Obese people (over 97th percentile) History of women's diseases and use of hormonal drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The beginning and end of the study (after three months). Method of measurement: A scale with an accuracy of 100 grams.;Waist circumference. Timepoint: The beginning and end of the study (after three months). Method of measurement: tape measure with an accuracy of 0.5 cm.;Body mass index. Timepoint: The beginning and end of the study (after three months). Method of measurement: The ratio of weight to the square of height.;Percentage of fat mass. Timepoint: The beginning and end of the study (after three months). Method of measurement: body composition analyzer (Omron).;Skeletal muscle percentage. Timepoint: The beginning and end of the study (after three months). Method of measurement: body composition analyzer (Omron).;Cardiorespiratory fitness. Timepoint: The beginning and end of the study (after three months). Method of measurement: 20 m shuttle run test.;Handgrip strength. Timepoint: The beginning and end of the study (after three months). Method of measurement: Handgrip.;Anaerobic power. Timepoint: The beginning and end of the study (after three months). Method of measurement: Standing broad jump. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression score. Timepoint: The beginning and end of the study (after three months). Method of measurement: PHQ-9 and DASS-21 questionnaires.;Anxiety score. Timepoint: The beginning and end of the study (after three months). Method of measurement: GAD-7 and DASS-21 questionnaires.;Stress score. Timepoint: The beginning and end of the study (after three months). Method of measurement: DASS-21 questionnaire.;Overall health score. Timepoint: The beginning and end of the study (after three months). Method of measurement: GHQ questionnaire.;The obtained score of premenstrual syndrome symptoms. Timepoint: The beginning and end of the study (after three months). Method of measurement: PSST questionnaire.;The obtained score of menstrual distress. Timepoint: The beginning and end of the study (after three months). Method of measurement: MMDQ questionnaire.;Sleep quality and quantity. Timepoint: The beginning and end of the study (after three months). Method of measurement: Pittsburgh Sleep Quality Index (PSQI).;Mental health. Timepoint: The beginning and end of the study (after three months). Method of measurement: SDQ questionnaire.;Health-related quality of life. Timepoint: The beginning and end of the study (after three months). Method of measurement: SF-36 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Moghtaderi
Yazd University of Medical Sciences
Outcome results
None listed